BRAINTEASER project aims to support patients with amyotrophic lateral sclerosis and multiple sclerosis and their clinicians. “Amyotrophic Lateral Sclerosis” campaign wants to bring attention to this condition and analyse the variables that might affect its progression. In “The use of biotelemetry to explore disease progression markers in amyotrophic lateral sclerosis” M. Kelly et al. report the results of an exploratory, non-controlled, nondrug study that aimed to objectively monitor ALS patients at home, to explore novel disease progression markers.
[Get to Know more about Amyotrophic Lateral Sclerosis] The use of biotelemetry to explore disease
OUR NEWSLETTER
Latest posts
Living with Amyotrophic Lateral Sclerosis
The BRAINTEASER Community of Practice Second webinar Advances in digital technology are...
Women in Multiple Sclerosis webinar: take-home messages
In the Webinar: Women in Multiple Sclerosis, hosted by the Community of Practice of the...
A glimpse into the multicentric observational study – Patient and physician perspectives from Lisbon
The Lisbon Academic Medical Center (Centro Académico de Medicina de Lisboa-CAML) is one of the...